Reproducibility crisis: Blame it on the antibodies
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These serum cTnI enrichment results illustrate the major benefits of functionalized NPs compared to current antibody-based approaches: (1) NPs are capable of reproducibly and effectively enriching cTnI (Supplementary Fig. 23) across all tested serum samples without the use of antibody, thus overcoming the intrinsic antibody-related limitations (vide supra)14,15,51–53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, these NPs can serve as replacements to conventional immuno-based techniques to overcome the antibody-related limitations in cTnI immunoassays and potentially address the current reproducibility crisis caused by antibodies in general14–16,51,53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Yet a recent survey found that 70% of scientists have tried and failed to reproduce results from a published experiment.1”
From Reproducibility of Quantitative Systems Pharmacology Models: Current Challenges and Future Opportunities (2019) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“However, antibodies possess many inherent limitations: batch-to-batch variation, high cost of production, poor chemical stability, and lack of proteoform-specific epitope recognition that collectively contribute to reproducibility issues [62–64].”
From Top-down proteomics: challenges, innovations, and applications in basic and clinical research (2020) · cites this paper as [63]
In the citing paper
“However, antibody-based platforms suffer from significant limitations including the batch-to-batch variability, high cost of the antibody production, and relatively low chemical stability14,15.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
Berglund, L., Björling, E., Oksvold, P., Fagerberg, L., Asplund, A., Al-Khalili Szigyarto, C., Persson, A., Ottosson, J., Wernérus, H., Nilsson, P., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800013-mcp200 · Cited by 672
Reproducibility: Standardize antibodies used in research
Bradbury, A., & Plückthun, A. (2015) · Nature · doi:10.1038/518027a · Cited by 647
Bordeaux, J., Welsh, A. W., Agarwal, S., Killiam, E., Baquero, M. T., Hanna, J. A., Anagnostou, V. K., & Rimm, D. L. (2010) · BioTechniques · doi:10.2144/000113382 · Cited by 589
An assessment of histone-modification antibody quality
Egelhofer, T. A., Minoda, A., Klugman, S., Lee, K., Kolasinska-Zwierz, P., Alekseyenko, A. A., Cheung, M.-S., Day, D. S., Gadel, S., Gorchakov, A. A., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1972 · Cited by 428
How reliable are G-protein-coupled receptor antibodies?
Michel, M. C., Wieland, T., & Tsujimoto, G. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0395-y · Cited by 306
Prassas, I., & Diamandis, E. P. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-1078 · Cited by 31
Cited by
Items 501–600 of 816
Liu, L., Wang, H., Sulemana, H., Xie, B., & Gao, L. (2023) · Biosensors · doi:10.3390/bios13030351 · Cited by 7
“Furthermore, immunoassays can produce false-positive or false-negative results [12].”
BackgroundAnkeny, R. A., Whittaker, A. L., Ryan, M., Boer, J. C., Plebanski, M., Tuke, J., & Spencer, S. J. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.012 · Cited by 7
“…reduce variation within experiments may limit the inferences that can be made to other laboratories with different experimental conditions, as well as producing misleading results (Richter et al., 2010; Richter et al., 2009) and contributing to the so-called ‘reproducibility crisis’ (Baker, 2015).”
BackgroundFaustini, S. E., Cook, A. M., Hill, H. J., Al‐Taei, S., Heaney, J. L. J., Efstathiou, E., Tanner, C., Townsend, N., Ahmed, Z., Dinally, M., et al. (2023) · Journal of Infection · doi:10.1016/j.jinf.2023.07.018 · Cited by 7
Detection and quantification of C-terminally tagged proteins by in-gel fluorescence
Fuchs, A. C. D. (2024) · Scientific Reports · doi:10.1038/s41598-024-66132-8 · Cited by 7
Global Proteomics Indicates Subcellular-Specific Anti-Ferroptotic Responses to Ionizing Radiation
Christopher, J. A., Breckels, L. M., Crook, O. M., Vázquez–Chantada, M., Barratt, D. G., & Lilley, K. S. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100888 · Cited by 8
A Computational Synaptic Antibody Characterization Tool for Array Tomography
Simhal, A. K., Gong, B., Trimmer, J. S., Weinberg, R. J., Smith, S. J., Sapiro, G., & Micheva, K. D. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00051 · Cited by 7
“A large volume of misleading data has been published based on results from antibodies that did not perform as assumed (Anderson and Grant, 2006; Rhodes and Trimmer, 2006; Baker, 2015).”
BackgroundTang, A. A.-S., Tiede, C., McPherson, M. J., & Tomlinson, D. C. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1126-5_6 · Cited by 7
Russo, G., Unkauf, T., Meier, D., Wenzel, E. V., Langreder, N., Schneider, K.-T., Wiesner, R., Bischoff, R., Stadler, V., & Dübel, S. (2022) · Biological Chemistry · doi:10.1515/hsz-2021-0405 · Cited by 7
“In the past years, a growing number of publications identified substantial problems with the quality of many of today’s research antibodies (Baker 2015; Bradbury and Plückthun 2015; Goodman 2018).”
BackgroundTriggle, C. R., & Williams, M. J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.08.089 · Cited by 7
Bubenheimer, R. K., Brown, I. A. M., Fried, D. E., McClain, J. L., & Gulbransen, B. D. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00073 · Cited by 8
Cao, Z., Zhang, W., Ning, X., Wang, B., Liu, Y., & Li, Q. X. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b03426 · Cited by 7
Kaminski, Z. J., Relich, I., Konieczna, I. M., Kaca, W., & Kolesińska, B. (2017) · Chemistry & Biodiversity · doi:10.1002/cbdv.201700444 · Cited by 7
Changing how we think about infectious diseases
Berman, J. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817576-7.00008-0 · Cited by 12
“The difficulties in verifying and reproducing the results obtained through precision measurements are a matter of deep concern to those who regulate new diagnostic tests [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] .”
Immunohistochemical Analysis of Opioid Receptors in Peripheral Tissues
Schmidt, Y., & Machelska, H. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1708-2_12 · Cited by 7
KDM3A is not associated with metastasis and prognosis of breast cancer
Yao, J., Zheng, S., Li, B., Li, X., & Liu, W. (2018) · Oncology Letters · doi:10.3892/ol.2018.8578 · Cited by 7
“First and foremost, given the importance of the accuracy and specificity of primary antibodies (27), the primary antibody against KDM3A used in our study was distinctly different from that employed by previous studies (14,28).”
ResultReader, P. P., Olkhov, R. V., Reeksting, S. B., Lubben, A., Hyde, C., & Shaw, A. M. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02029-0 · Cited by 7
Bleakley, C., Reijgers, J., & Smoliga, J. M. (2020) · Journal of Orthopaedic and Sports Physical Therapy · doi:10.2519/jospt.2020.9264 · Cited by 9
Bulker: a multi-container environment managerPreprint
Sheffield, N. C. (2019) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/natsj · Cited by 7
The Recombinant Antibodies & Mimetics Database: Redefining the future of antibody use in science
Modi, S. (2025) · Alternatives to Laboratory Animals · doi:10.1177/02611929251371129 · Cited by 6
“8 A call to the scienti fi c community for a validated solution: Non-animal-derived antibodies In response to these challenges, the EURL ECVAM Sci-enti fi c Advisory Committee (ESAC) reviewed the evidence supporting animal-free antibody technologies.”
Burd, B. S., Trombotto, B., da Cunha, G. E. R., Floriano, J. F., Garcia, M. T., Brasil, G. S. P., dos Santos, L. S., Guerra, N. B., Polanczyk, R. A., Persinoti, G. F., et al. (2026) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2026.122471 · Cited by 7
Science and Sentiment: Grinnell’s Fact-Based Philosophy of Biodiversity Conservation
Shavit, A., & Griesemer, J. R. (2017) · Journal of the History of Biology · doi:10.1007/s10739-017-9489-4 · Cited by 6
“Traceable and open-access information to the full context behind one’s results – or its lack – has been at the core of the recent ‘‘problem of replication’’ heavily discussed in Nature (Baker, 2015; Russell, 2013), and the reason for major editorial changes taken by Nature (editorial 2014), Science (Mcnutt, 2014) and…”
BackgroundPEGR: a flexible management platform for reproducible epigenomic and genomic research
Shao, D., Kellogg, G. D., Nematbakhsh, A., Kuntala, P. K., Mahony, S., Pugh, B. F., & Lai, W. (2022) · Genome biology · doi:10.1186/s13059-022-02671-5 · Cited by 7
“has been a longtime challenge across many scientific fields [1-3].”
BackgroundPurcell, R. A., Aurelia, L. C., Esterbauer, R., Allen, L. F., Bond, K. A., Williamson, D. A., Trevillyan, J. M., Trubiano, J. A., Juno, J. A., Wheatley, A. K., et al. (2024) · Clinical & Translational Immunology · doi:10.1002/cti2.1494 · Cited by 7
“1,2 This is typically a ramification of antibody cross-reactivity or inappropriate use of antibody reagents in applications for which they have not been validated.”
BackgroundNano‐Phase Separation and Analyte Binding in Aptasensors Investigated by Nano‐IR Spectroscopy
Samiseresht, N., Miranda, G. F., Das, A., Graef, K., Mayer, D., & Rabe, M. (2025) · Small · doi:10.1002/smll.202409369 · Cited by 6
Two‐Step Co‐Immunoprecipitation (TIP)
Sciuto, M. R., Coppola, V., Iannolo, G., Maria, R. D., & Haas, T. L. (2018) · Current Protocols in Molecular Biology · doi:10.1002/cpmb.80 · Cited by 6
“(1) The quality of the antibodies used for the experiments is of highest importance to avoid problems such as inefficient precipitation or abundant nonspecific interactions that may arise due to the poor affinities and/or cross-reactivity of many commercially available antibodies (Baker, 2015).”
BackgroundBob-Manuel, J., & Gautron, L. (2021) · Journal of Visualized Experiments · doi:10.3791/62945 · Cited by 7
Previously Unrecognized Nonreproducible Antibody–Probe Interactions
Pan, J., Yang, L., Deng, Y., Sun, B., Zhang, L., Wu, W., Li, J., Cheng, H., Li, Y., Xu, W., et al. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03264 · Cited by 6
Aptamer-based Emerging Tools for Viral Biomarker Detection: A Focus on SARS-CoV-2
Kulabhusan, P. K., Pishva, P., Çapkın, E., Tambe, P., & Yüce, M. (2022) · Current Medicinal Chemistry · doi:10.2174/1568009622666220214101059 · Cited by 7
Gales, A., Monteiro‐Pai, S., & Hyndman, K. A. (2022) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2022-0126 · Cited by 6
A decade of GigaScience: What can be learned from half a million RRIDs in the scientific literature?
Bandrowski, A. E. (2022) · GigaScience · doi:10.1093/gigascience/giac058 · Cited by 10
“Antibody problems have long been opprobriated as a major driver of irreproducibility [3] and many solutions have been proposed to alleviate the problems with antibodies ranging from eliminating all polyclonals [4], to adding validation data for each antibody used [5].”
BackgroundWhiteaker, J. R., Zhao, L., Schoenherr, R. M., Huang, D., Lundeen, R. A., Voytovich, U. J., Kennedy, J. J., Ivey, R. G., Lin, C., Murillo, O. D., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1168710 · Cited by 7
Nucleocapsid protein binding DNA aptamers for detection of SARS-COV-2
Neff, C. P., Cikara, M., Geiss, B. J., Caltagirone, G. T., Liao, A. M., Atif, S. M., Macdonald, B., & Schaden, R. (2023) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2023.100132 · Cited by 6
“…similar characteristics to antibodies in that they bind specifically to their targets (Tuerk and Gold 1990) but can be synthesized in a fraction of the time and cost (Lakhin, et al. 2013, Baker 2015) and are temperature and pH resistant(Chen and Yang 2015) suggestive of them being very stable.”
Sachse, M., de Castro, I. F., Tenorio, R., & Risco, C. (2023) · Molecular Microbiology · doi:10.1111/mmi.15182 · Cited by 6
“However, it normally requires some tests whether an antibody really recognizes and binds specific to your epitope of interest (Baker, 2015).”
BackgroundsiRNA knockdown validation 101: Incorporating negative controls in antibody research
Olds, W., & Li, J. (2016) · F1000Research · doi:10.12688/f1000research.8159.1 · Cited by 6
PIK3CD promoted proliferation in diffuse large B cell lymphoma through upregulation of c-myc
Cui, W., Zheng, S., Li, X., Ma, Y., Sang, W., Liu, M., Zhang, W., & Zhou, X. (2016) · Tumor Biology · doi:10.1007/s13277-016-5225-5 · Cited by 6
“At last, the specificity and correctness of primary antibody used [25] might be also potential factors that have been reported to be able to result in the biased results.”
BackgroundMethodChou, C., Liu, Y., Chen, Y., Huang, P., Tsou, P.-H., Chen, C., Lee, H., Wang, Y., Hsu, J. L., Lee, J.-F., et al. (2020) · ACS Sensors · doi:10.1021/acssensors.9b01736 · Cited by 6
The effect of journal guidelines on the reporting of antibody validation
Hoek, J. M., Hepkema, W. M., & Halffman, W. (2020) · PeerJ · doi:10.7717/peerj.9300 · Cited by 6
“82 For over a decade, various researchers have expressed concerns about insufficient 83 antibody validation in biomedical research (Baker 2015a; Bordeaux et al. 2010; Saper & 84 Sawchenko 2003).”
BackgroundQuantitative Synaptic Biology: A Perspective on Techniques, Numbers and Expectations
Reshetniak, S., Fernández‐Busnadiego, R., Müller, M., Rizzoli, S. O., & Tetzlaff, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197298 · Cited by 6
“IgGs are among the most commonly employed tools for protein imaging [68,69], but their quality and reproducibility are known to be inconsistent [70,71], even for conventional imaging assays.”
BackgroundBrands, J., Steffen, F., Spennes, J., Leeb, T., & Bilzer, T. (2020) · Muscle & Nerve · doi:10.1002/mus.27162 · Cited by 6
“Alternatively, it might result from cross reactions with other proteins or variability of the antibodies used.(28) Muscle atrophy and adipose tissue distribution in G2 was excessive and present in both superficial gluteus and semimembranosus muscle (Figure 3C).”
BackgroundGisdon, F. J., Kynast, J. P., Ayyildiz, M., Hine, A. V., Plückthun, A., & Höcker, B. (2022) · Biological Chemistry · doi:10.1515/hsz-2021-0384 · Cited by 8
“But apart from that, increasing awareness arose from the observation that animal-derived antibodies are varying between separate batches and often lack distinct specificity, which affects experimental reproducibility (Baker 2015).”
BackgroundWinsnes, A., Ivarsson, M.-L., Falk, P., Gunnarsson, U., & Strigård, K. (2022) · Hernia · doi:10.1007/s10029-022-02664-0 · Cited by 7
“IHC staining has several sources of error including nonspecificity of antibodies [32].”
BackgroundA Database of Accurate Electrophoretic Migration Patterns for Human Proteins
Mylonas, R., Potts, A., Waridel, P., Barblan, J., Rubio, M. D. C. C., Widmann, C., & Quadroni, M. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167933 · Cited by 8
Guan, P., Guo, Z., Xu, S., Hai-feng, L., Wang, L., Gu, Z., & Liu, Z. (2023) · Angewandte Chemie · doi:10.1002/ange.202301202 · Cited by 6
Reproducibility in Biomedical Research
Mullane, K., Curtis, M. J., & Williams, M. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804725-5.00001-x · Cited by 11
Identification of Leptin Receptor–Expressing Cells in the Nodose Ganglion of Male Mice
Mercado, L. L., Caron, A., Wang, Y., Burton, M. D., & Gautron, L. (2019) · Endocrinology · doi:10.1210/en.2019-00021 · Cited by 7
Specificity of research antibodies: “trust is good, validation is better”
Ogris, E., Sontag, E., Wadzinski, B. E., & Narla, G. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.12.003 · Cited by 7
The Molecular Toolbox for Linkage Type‐Specific Analysis of Ubiquitin Signaling
Koch, J., Elbæk, C. R., Priesmann, D., & Damgaard, R. B. (2025) · ChemBioChem · doi:10.1002/cbic.202500114 · Cited by 5
Aeffner, F., Bolon, B. N., Boyle, M. H., Buetow, B. S., Forest, T. W., Janardhan, K. S., Mansfield, K. G., Meyerholz, D. K., Price, S. A., & Rebelatto, M. C. (2025) · Toxicologic Pathology · doi:10.1177/01926233251393154 · Cited by 7
“7 Therefore, after evaluating the IHC-stained sections, particularly during a study for target tissue characterization of a relatively novel IHC target, the pathologist should review the data in the context of other internal or publicly available data on expression of the target antigen.”
Scalable Multiparametric Characterization of Aptamer–Target Interactions
Sulliger, M., Peters, M., Sottini, A., Stuber, A., Yang, K.-A., Nakatsuka, N., Arroyo, J. O., & Quidant, R. (2026) · ACS Nano · doi:10.1021/acsnano.5c19596 · Cited by 5
Antibody reliability influences observed mRNA–protein correlations in tumour samples
Upadhya, S. R., & Ryan, C. J. (2023) · Life Science Alliance · doi:10.26508/lsa.202201885 · Cited by 5
“The issue of antibody reliability is a general challenge for biological studies, not just those that make use of RPPA (Baker, 2015; Goodman, 2018).”
Novotný, J., Svobodová, Z., Ilicova, M., Hruskova, D., Košťálová, J., Bílková, Z., & Foret, F. (2024) · Microchimica Acta · doi:10.1007/s00604-024-06512-z · Cited by 5
Antibody selection and automated quantification of TRPV1 immunofluorescence on human skin
Jin, Y., Brennecke, J., Sodmann, A., Blum, R., & Sommer, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-79271-9 · Cited by 7
Wang, B., Kim, H.-J., Bradley, K. M., Chen, C., McLendon, C., Yang, Z., & Benner, S. A. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c11043 · Cited by 5
Performance of novel tau antibodies across multiple modalities for Alzheimer's disease assessment
Trivedi, P., Forrest, K., Fisher, D. W., Winstone, J. K., McMillan, P. J., Valentine, M., Postupna, N. O., Wilson, A., Bajwa, T. S., MacCoss, M. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70481 · Cited by 6
“55,58 Synthetic tryptic peptides were chosen as immunogens to generate antibodies against peptides that could be used in trypsin digestion– peptide immunoenrichment–LC-MS/MS assays (which are still being pursued).”
Antibody Validation for Estrogen Receptor Beta
Birgersson, M., Katona, B., Lindskog, C., Pontén, F., & Williams, C. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1920-9_1 · Cited by 5
Sun, L. Z., Xu, Y., Dube, N., Anderson, M., Breidinger, S., Vaddady, P. K., Thornton, B., Morrow, L., Matthews, R. P., Stoch, S. A., et al. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2022.114639 · Cited by 7
Li, Z., Li, X., Xian, W., Xie, H., Sun, Y., Zhang, Y., Wang, J., Li, H., Jin, C., Liu, X., et al. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00255h · Cited by 5
Progress and Remaining Opportunities to Increase the Use of Animal-free Antibodies in the USA
Groff, K., Allen, D., Casey, W., & Clippinger, A. J. (2024) · Alternatives to Laboratory Animals · doi:10.1177/02611929241266472 · Cited by 5
Kamran, A., Hussain, M. D., Farooq, T., Li, F., Khan, M., Li, X., Yang, S., & Xie, X. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127940 · Cited by 6
RETRACTED ARTICLE: KDM3A confers metastasis and chemoresistance in epithelial ovarian cancer
Pa, M., Naizhaer, G., Seyiti, A., & Kuerbang, G. (2015) · Journal of Molecular Histology · doi:10.1007/s10735-015-9642-3 · Cited by 6
“Secondly, considering that the specificity of primary antibodies used could lead to the irreproducibility of biomedical research (Baker 2015; Holmseth et al. 2012), all the primary antibodies should have been evaluated and tested prior to being used.”
BackgroundRetractedAntibodies Versus Aptamers: A Comparative View
Alsager, O. A., Eissa, S., & Zourob, M. M. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016162-00303 · Cited by 8
A Case Report: Building communities with training and resources for Open Science trainers
Brinken, H., Kuchma, I., Kalaitzi, V., Davidson, J., Pontika, N., Cancellieri, M., Correia, A., Carvalho, J., Melero, R., Kastelic, D., et al. (2019) · LIBER Quarterly The Journal of the Association of European Research Libraries · doi:10.18352/lq.10303 · Cited by 8
“Poor reproducibility of preclinical research has been identified as one potential cause for the limited success of drug or treatment development (Baker, 2015; Jarvis & Williams, 2016).”
BackgroundGabr, M. T., Balupuri, A., & Kang, N. S. (2020) · ACS Sensors · doi:10.1021/acssensors.0c00897 · Cited by 5
Measuring and interpreting pervasive heterogeneity, poikilosis
Vihinen, M. (2021) · FASEB BioAdvances · doi:10.1096/fba.2021-00015 · Cited by 6
MALDI-TOF-MS-Based Identification of Monoclonal Murine Anti-SARS-CoV-2 Antibodies within One Hour
Tscheuschner, G., Kaiser, M. N., Lisec, J., Beslic, D., Muth, T., Krüger, M., Mages, H. W., Dorner, B. G., Knospe, J., Schenk, J. A., et al. (2022) · Antibodies · doi:10.3390/antib11020027 · Cited by 5
Sripattanakul, S., Prapong, T., Kamlangdee, A., Katzenmeier, G., Haltrich, D., Hongprayoon, R., & Prapong, S. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7100311 · Cited by 5
“The different conditions of each method can affect protein folding and, therefore, its binding ability [73].”
BackgroundSurface imprinted bio‐nanocomposites for affinity separation of a cellular DNA repair protein
Xie, H., Sun, Y., Zhang, R., Zhang, Y., & Zhao, M. (2023) · Biopolymers · doi:10.1002/bip.23537 · Cited by 5
An oxide transport chain essential for balanced insulin action
Wu, X., Chen, K., & Williams, K. J. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.02.006 · Cited by 5
Genetic and functional analysis of a Pacific hagfish opioid system
Huang, A., Taylor, A. M. W., Ghogha, A., Pribadi, M., Wang, Q., Kim, T. S. J., Cahill, C. M., Coppola, G., & Evans, C. J. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24682 · Cited by 5
“…bioassays (some opioid-like effects require very high ligand concentrations and some are non-naloxone reversible or naloxone has agonist effects) and the inherent problems with immune detection (Baker, 2015), genome sequence authentication is necessary to rigorously confirm signal identity.”
BackgroundAffiblot: a dot blot-based screening device for selection of reliable antibodies
Svobodová, Z., Novotný, J., Ospalkova, B., Slováková, M., Bílková, Z., & Foret, F. (2021) · Analytical Methods · doi:10.1039/d1ay00955a · Cited by 6
An evaluation of different Cripto‐1 antibodies and their variable results
Gudbergsson, J. M., & Duroux, M. C. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29293 · Cited by 5
“Even translational research and clinical trials have been terminated due to cross‐reactivity issues and irreproducibility of antibody binding, with tremendous scientific and financial consequences.(27,32) Since our experimental results made us question cripto‐1 antibody specificity, we did a systematic review of the l…”
BackgroundBron, R., & Bunnett, N. W. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00312.2015 · Cited by 5
Multiplexing and Beyond in Biobehavioral Research
Mills, P. J., & Peterson, C. T. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000329 · Cited by 6
“This merits significant attention because antibody quality can be poor (12,13) and has been cited as a contributor to the current reproducibility crisis in biomedical science (14).”
BackgroundMullan, C. W., Summer, L. C., López‐Giráldez, F., Tobiásová, Z., Manes, T. D., Yasothan, S., Song, G., Jane‐wit, D., Saltzman, W. M., & Pober, J. S. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400331 · Cited by 4
Open-source antibodies as a path to enhanced research reproducibility and transparency
Rego, M. A., Houston, D. W., Fan, M., Murray, K. D., & Trimmer, J. S. (2025) · New Biotechnology · doi:10.1016/j.nbt.2025.04.004 · Cited by 5
Investigation of Body Fluids Intervention Impact on Aptamer Screening via Capillary Electrophoresis
Zhu, C., Chen, L., Wei, B., Yang, G. H., Zhao, L., & Qu, F. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c00369 · Cited by 4
Phochantachinda, S., Photcharatinnakorn, P., Chatchaisak, D., Sakcamduang, W., Chansawhang, A., Buranasinsup, S., Suemanotham, N., & Chantong, B. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321509 · Cited by 6
“Although traditional methods, such as western blotting and ELISA, are commonly used, they face challenges, including limited antibody specificity and throughput [103,104].”
Choi, D., An, J.-H., Lee, N., Park, H., & Kong, M. (2026) · Talanta · doi:10.1016/j.talanta.2026.129595 · Cited by 4
Miri, Z., Laakkonen, J., Toivonen, E., Väljä, N., Miettinen, S., & Vuorenpää, H. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1741716 · Cited by 4
“Here, we provide insights on how researchers can do a controlled shift from animal-derived cell culture process towards animal-free in vitro modeling while increasing the specificity of their antibodies (Baker, 2015; Bradbury and Plückthun, 2015).”
Avoiding experimental bias by systematic antibody validation
Jager, S. E., & Vægter, C. B. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.187037 · Cited by 4
“with scientific reproducibility problems (Baker, 2015).”
BackgroundTargeted Proteomics to Study Mitochondrial Biology
Wolters, J. C., Permentier, H. P., Bakker, B. M., & Bischoff, R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8367-0_7 · Cited by 4
Lanham, D. (2021) · Bioanalysis · doi:10.4155/bio-2020-0320 · Cited by 4
Ciencia Abierta: desafíos y oportunidades para Uruguay y el Sur Global
Prieto, D. (2022) · Informatio · doi:10.35643/info.27.1.5 · Cited by 11
Two-sample t α -test for testing hypotheses in small-sample experiments
Tan, Y.-D. (2022) · The International Journal of Biostatistics · doi:10.1515/ijb-2021-0047 · Cited by 5
Hermawaty, D., Cahn, J., Lister, R., & Considine, M. (2023) · Tree Physiology · doi:10.1093/treephys/tpac146 · Cited by 2
MILKSHAKE Western blot and Sundae ELISA: We all scream for better antibody validation
Mendez, Q. M., Driscoll, H. A., Mirando, G. R., Acca, F. E., Chapados, C. D., Jones, K. S., Weiner, M. P., Li, X., & Ferguson, M. R. (2023) · Journal of Immunological Methods · doi:10.1016/j.jim.2023.113540 · Cited by 4
High-Efficiency Genomic Mapping of Chromatin-Associated Targets with CUT&RUN
Firestone, T. M., Venters, B. J., Novitzky, K., Albertorio-Sáez, L. M., Barnes, C. A., Fedder-Semmes, K. N., Hall, N. W., Hickman, A. R., Kaderli, M., Lin, C. P., et al. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5072-1_5 · Cited by 4
Localizations of Laminin Chains Suggest Their Multifaceted Functions in Mouse Tooth Development
Liang, T., Zhang, H., Hu, Y., Solanki, M., Zhang, C., Sasaki, T., Smith, C. E., Hu, J. C. ‐., & Simmer, J. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094134 · Cited by 5
Ch’ng, J.-H., Sirel, M., Zandian, A., Quintana, M. D. P., Chan, S. C. L., Moll, K., Tellgren‐Roth, Å., Nilsson, I., Nilsson, P., Qundos, U., et al. (2017) · Scientific Reports · doi:10.1038/srep43190 · Cited by 4
Southan, C., Sharman, J. L., Faccenda, E., Pawson, A. J., Harding, S. D., & Davies, J. A. (2018) · ACS Omega · doi:10.1021/acsomega.8b00884 · Cited by 4
“13 At about the same time, concerns were being raised about the inappropriate use of statistics and other aspects of experimental design, which prompted revisions of the author guidelines for the Br. J. Pharmacol.”
Generation of CoilR Probe Peptides for VIPER-labeling of Cellular Proteins
Doh, J. K., Tobin, S. J., & Beatty, K. E. (2019) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3412 · Cited by 4
“Many antibodies have poor target specificity and cross-reactivity (Berglund et al., 2008; Bordeaux et al., 2010; Baker, 2015; Bradbury and Pluckthun, 2015), which can result in misleading observations.”
BackgroundImaging VIPER-labeled Cellular Proteins by Correlative Light and Electron Microscopy
Doh, J. K., Chang, Y. H., Enns, C. A., Lόpez, C., & Beatty, K. E. (2019) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3414 · Cited by 4
“DOI:10.21769/BioProtoc.3414 www.bio-protocol.org/e3414 (Berglund et al., 2008; Bordeaux et al., 2010; Baker, 2015; Bradbury and Pluckthun, 2015).”
InfluentialAntibody Specificity Profiling Using Protein Microarrays
Ramos-López, P., Irizarry, J., Pino, I., & Blackshaw, S. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7841-0_14 · Cited by 4
Protein fishing from single live cells
Shekaramiz, E., Doshi, R., & Wickramasinghe, H. K. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0395-5 · Cited by 4
Considerations on Using Antibodies for Studying the Dynorphins/Kappa Opioid Receptor System
Chen, C., Widmann, M., Schwarzer, C., & Liu‐Chen, L. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_467 · Cited by 5
Immunohistochemical Analysis of Opioid Receptors in Peripheral Tissues
Schmidt, Y., & Machelska, H. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0884-5_7 · Cited by 4
Proteomics: Its Promise and Pitfalls in Shaping Precision Medicine in Solid Organ Transplantation
Farkona, S., Pastrello, C., & Konvalinka, A. (2023) · Transplantation · doi:10.1097/tp.0000000000004539 · Cited by 5
Insulin-secreting β cells require a post-genomic concept
Jiang, F., & Morahan, G. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i10.198 · Cited by 6
Primary and Secondary Antibodies and Flow Cytometry Controls
Hammerbeck, C. D., Goetz, C. A., & Bonnevier, J. L. (2018) · Techniques in life science and biomedicine for the non-expert · doi:10.1007/978-3-319-98071-3_6 · Cited by 4
Harms, R. Z., Borengasser, K., Kumar, V., & Sarvetnick, N. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00046 · Cited by 4
“The problems of antibody specificity, validation, and the associated “reproducibility crisis” have been on display for some time (Saper, 2009; Voskuil, 2014; Baker, 2015; Weller, 2016).”
Background
Metadata
- Authors
- Baker, M.
- Corresponding author
- Baker, Monya
- Venue
- Nature
- Published
- 2015-05-19
- Volume
- 521
- Issue
- 7552
- Pages
- 274-276
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1592986776
- Cited by
- 830
- References
- 7
- Citations by year
- 2026: 55 · 2025: 58 · 2024: 56 · 2023: 57 · 2022: 67 · 2021: 68 · 2020: 78 · 2019: 75 · 2018: 87 · 2017: 93 · 2016: 83 · 2015: 51
- Type
- other
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Keywords
- replication crisis, immunoglobulins, antibody validation, scientific rigor, research integrity
- MeSH terms
- Antibodies, Antibody Specificity, Cross Reactions, Humans, Indicators and Reagents, Membrane Proteins, Quality Control, Reagent Kits, Diagnostic, Reproducibility of Results, Artifacts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.